 | • レポートコード：MRC2-11QY05698 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は末期腎疾患治療のグローバル市場について調査・分析したレポートです。種類別（MK-3866、パクリチニブ、サングイネート、テシドルマブ、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別末期腎疾患治療の競争状況、市場シェア ・世界の末期腎疾患治療市場：種類別市場規模 2015年-2020年（MK-3866、パクリチニブ、サングイネート、テシドルマブ、その他） ・世界の末期腎疾患治療市場：種類別市場規模予測 2021年-2026年（MK-3866、パクリチニブ、サングイネート、テシドルマブ、その他） ・世界の末期腎疾患治療市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界の末期腎疾患治療市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米の末期腎疾患治療市場分析：米国、カナダ ・ヨーロッパの末期腎疾患治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの末期腎疾患治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の末期腎疾患治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの末期腎疾患治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：BLR Bio LLC、CTI BioPharma Corp、F. Hoffmann-La Roche Ltd、Novartis AG、Prolong Pharmaceuticals LLC、VESSL Therapeutics Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global End-Stage Kidney Disease Treatment Market
The global End-Stage Kidney Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global End-Stage Kidney Disease Treatment Scope and Market Size
End-Stage Kidney Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global End-Stage Kidney Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the End-Stage Kidney Disease Treatment market is segmented into
MK-3866
Pacritinib
Sanguinate
Tesidolumab
Others
Segment by Application, the End-Stage Kidney Disease Treatment market is segmented into
Clinic
Hospital
Others
Regional and Country-level Analysis
The End-Stage Kidney Disease Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the End-Stage Kidney Disease Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and End-Stage Kidney Disease Treatment Market Share Analysis
End-Stage Kidney Disease Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in End-Stage Kidney Disease Treatment business, the date to enter into the End-Stage Kidney Disease Treatment market, End-Stage Kidney Disease Treatment product introduction, recent developments, etc.
The major vendors covered:
BLR Bio LLC
CTI BioPharma Corp
F. Hoffmann-La Roche Ltd
Novartis AG
Prolong Pharmaceuticals LLC
VESSL Therapeutics Ltd
…
1 Study Coverage
1.1 End-Stage Kidney Disease Treatment Product Introduction
1.2 Market Segments
1.3 Key End-Stage Kidney Disease Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global End-Stage Kidney Disease Treatment Market Size Growth Rate by Type
1.4.2 MK-3866
1.4.3 Pacritinib
1.4.4 Sanguinate
1.4.5 Tesidolumab
1.4.6 Others
1.5 Market by Application
1.5.1 Global End-Stage Kidney Disease Treatment Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global End-Stage Kidney Disease Treatment Market Size, Estimates and Forecasts
2.1.1 Global End-Stage Kidney Disease Treatment Revenue 2015-2026
2.1.2 Global End-Stage Kidney Disease Treatment Sales 2015-2026
2.2 Global End-Stage Kidney Disease Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global End-Stage Kidney Disease Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global End-Stage Kidney Disease Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global End-Stage Kidney Disease Treatment Competitor Landscape by Players
3.1 End-Stage Kidney Disease Treatment Sales by Manufacturers
3.1.1 End-Stage Kidney Disease Treatment Sales by Manufacturers (2015-2020)
3.1.2 End-Stage Kidney Disease Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 End-Stage Kidney Disease Treatment Revenue by Manufacturers
3.2.1 End-Stage Kidney Disease Treatment Revenue by Manufacturers (2015-2020)
3.2.2 End-Stage Kidney Disease Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global End-Stage Kidney Disease Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by End-Stage Kidney Disease Treatment Revenue in 2019
3.2.5 Global End-Stage Kidney Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 End-Stage Kidney Disease Treatment Price by Manufacturers
3.4 End-Stage Kidney Disease Treatment Manufacturing Base Distribution, Product Types
3.4.1 End-Stage Kidney Disease Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers End-Stage Kidney Disease Treatment Product Type
3.4.3 Date of International Manufacturers Enter into End-Stage Kidney Disease Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global End-Stage Kidney Disease Treatment Market Size by Type (2015-2020)
4.1.1 Global End-Stage Kidney Disease Treatment Sales by Type (2015-2020)
4.1.2 Global End-Stage Kidney Disease Treatment Revenue by Type (2015-2020)
4.1.3 End-Stage Kidney Disease Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global End-Stage Kidney Disease Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global End-Stage Kidney Disease Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global End-Stage Kidney Disease Treatment Revenue Forecast by Type (2021-2026)
4.2.3 End-Stage Kidney Disease Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global End-Stage Kidney Disease Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global End-Stage Kidney Disease Treatment Market Size by Application (2015-2020)
5.1.1 Global End-Stage Kidney Disease Treatment Sales by Application (2015-2020)
5.1.2 Global End-Stage Kidney Disease Treatment Revenue by Application (2015-2020)
5.1.3 End-Stage Kidney Disease Treatment Price by Application (2015-2020)
5.2 End-Stage Kidney Disease Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global End-Stage Kidney Disease Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global End-Stage Kidney Disease Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global End-Stage Kidney Disease Treatment Price Forecast by Application (2021-2026)
6 North America
6.1 North America End-Stage Kidney Disease Treatment by Country
6.1.1 North America End-Stage Kidney Disease Treatment Sales by Country
6.1.2 North America End-Stage Kidney Disease Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America End-Stage Kidney Disease Treatment Market Facts & Figures by Type
6.3 North America End-Stage Kidney Disease Treatment Market Facts & Figures by Application
7 Europe
7.1 Europe End-Stage Kidney Disease Treatment by Country
7.1.1 Europe End-Stage Kidney Disease Treatment Sales by Country
7.1.2 Europe End-Stage Kidney Disease Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe End-Stage Kidney Disease Treatment Market Facts & Figures by Type
7.3 Europe End-Stage Kidney Disease Treatment Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific End-Stage Kidney Disease Treatment by Region
8.1.1 Asia Pacific End-Stage Kidney Disease Treatment Sales by Region
8.1.2 Asia Pacific End-Stage Kidney Disease Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific End-Stage Kidney Disease Treatment Market Facts & Figures by Type
8.3 Asia Pacific End-Stage Kidney Disease Treatment Market Facts & Figures by Application
9 Latin America
9.1 Latin America End-Stage Kidney Disease Treatment by Country
9.1.1 Latin America End-Stage Kidney Disease Treatment Sales by Country
9.1.2 Latin America End-Stage Kidney Disease Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America End-Stage Kidney Disease Treatment Market Facts & Figures by Type
9.3 Central & South America End-Stage Kidney Disease Treatment Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa End-Stage Kidney Disease Treatment by Country
10.1.1 Middle East and Africa End-Stage Kidney Disease Treatment Sales by Country
10.1.2 Middle East and Africa End-Stage Kidney Disease Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa End-Stage Kidney Disease Treatment Market Facts & Figures by Type
10.3 Middle East and Africa End-Stage Kidney Disease Treatment Market Facts & Figures by Application
11 Company Profiles
11.1 BLR Bio LLC
11.1.1 BLR Bio LLC Corporation Information
11.1.2 BLR Bio LLC Description and Business Overview
11.1.3 BLR Bio LLC Sales, Revenue and Gross Margin (2015-2020)
11.1.4 BLR Bio LLC End-Stage Kidney Disease Treatment Products Offered
11.1.5 BLR Bio LLC Related Developments
11.2 CTI BioPharma Corp
11.2.1 CTI BioPharma Corp Corporation Information
11.2.2 CTI BioPharma Corp Description and Business Overview
11.2.3 CTI BioPharma Corp Sales, Revenue and Gross Margin (2015-2020)
11.2.4 CTI BioPharma Corp End-Stage Kidney Disease Treatment Products Offered
11.2.5 CTI BioPharma Corp Related Developments
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Corporation Information
11.3.2 F. Hoffmann-La Roche Ltd Description and Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Products Offered
11.3.5 F. Hoffmann-La Roche Ltd Related Developments
11.4 Novartis AG
11.4.1 Novartis AG Corporation Information
11.4.2 Novartis AG Description and Business Overview
11.4.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis AG End-Stage Kidney Disease Treatment Products Offered
11.4.5 Novartis AG Related Developments
11.5 Prolong Pharmaceuticals LLC
11.5.1 Prolong Pharmaceuticals LLC Corporation Information
11.5.2 Prolong Pharmaceuticals LLC Description and Business Overview
11.5.3 Prolong Pharmaceuticals LLC Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Products Offered
11.5.5 Prolong Pharmaceuticals LLC Related Developments
11.6 VESSL Therapeutics Ltd
11.6.1 VESSL Therapeutics Ltd Corporation Information
11.6.2 VESSL Therapeutics Ltd Description and Business Overview
11.6.3 VESSL Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Products Offered
11.6.5 VESSL Therapeutics Ltd Related Developments
11.1 BLR Bio LLC
11.1.1 BLR Bio LLC Corporation Information
11.1.2 BLR Bio LLC Description and Business Overview
11.1.3 BLR Bio LLC Sales, Revenue and Gross Margin (2015-2020)
11.1.4 BLR Bio LLC End-Stage Kidney Disease Treatment Products Offered
11.1.5 BLR Bio LLC Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 End-Stage Kidney Disease Treatment Market Estimates and Projections by Region
12.1.1 Global End-Stage Kidney Disease Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global End-Stage Kidney Disease Treatment Revenue Forecast by Regions 2021-2026
12.2 North America End-Stage Kidney Disease Treatment Market Size Forecast (2021-2026)
12.2.1 North America: End-Stage Kidney Disease Treatment Sales Forecast (2021-2026)
12.2.2 North America: End-Stage Kidney Disease Treatment Revenue Forecast (2021-2026)
12.2.3 North America: End-Stage Kidney Disease Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe End-Stage Kidney Disease Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: End-Stage Kidney Disease Treatment Sales Forecast (2021-2026)
12.3.2 Europe: End-Stage Kidney Disease Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: End-Stage Kidney Disease Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific End-Stage Kidney Disease Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: End-Stage Kidney Disease Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: End-Stage Kidney Disease Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: End-Stage Kidney Disease Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America End-Stage Kidney Disease Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: End-Stage Kidney Disease Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: End-Stage Kidney Disease Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: End-Stage Kidney Disease Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa End-Stage Kidney Disease Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: End-Stage Kidney Disease Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: End-Stage Kidney Disease Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: End-Stage Kidney Disease Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key End-Stage Kidney Disease Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 End-Stage Kidney Disease Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. End-Stage Kidney Disease Treatment Market Segments
Table 2. Ranking of Global Top End-Stage Kidney Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global End-Stage Kidney Disease Treatment Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of MK-3866
Table 5. Major Manufacturers of Pacritinib
Table 6. Major Manufacturers of Sanguinate
Table 7. Major Manufacturers of Tesidolumab
Table 8. Major Manufacturers of Others
Table 9. Global End-Stage Kidney Disease Treatment Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global End-Stage Kidney Disease Treatment Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global End-Stage Kidney Disease Treatment Sales by Regions 2015-2020 (K Pcs)
Table 12. Global End-Stage Kidney Disease Treatment Sales Market Share by Regions (2015-2020)
Table 13. Global End-Stage Kidney Disease Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global End-Stage Kidney Disease Treatment Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global End-Stage Kidney Disease Treatment Sales Share by Manufacturers (2015-2020)
Table 16. Global End-Stage Kidney Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global End-Stage Kidney Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in End-Stage Kidney Disease Treatment as of 2019)
Table 18. End-Stage Kidney Disease Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. End-Stage Kidney Disease Treatment Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers End-Stage Kidney Disease Treatment Price (2015-2020) (USD/Pcs)
Table 21. End-Stage Kidney Disease Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers End-Stage Kidney Disease Treatment Product Type
Table 23. Date of International Manufacturers Enter into End-Stage Kidney Disease Treatment Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global End-Stage Kidney Disease Treatment Sales by Type (2015-2020) (K Pcs)
Table 26. Global End-Stage Kidney Disease Treatment Sales Share by Type (2015-2020)
Table 27. Global End-Stage Kidney Disease Treatment Revenue by Type (2015-2020) (US$ Million)
Table 28. Global End-Stage Kidney Disease Treatment Revenue Share by Type (2015-2020)
Table 29. End-Stage Kidney Disease Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global End-Stage Kidney Disease Treatment Sales by Application (2015-2020) (K Pcs)
Table 31. Global End-Stage Kidney Disease Treatment Sales Share by Application (2015-2020)
Table 32. North America End-Stage Kidney Disease Treatment Sales by Country (2015-2020) (K Pcs)
Table 33. North America End-Stage Kidney Disease Treatment Sales Market Share by Country (2015-2020)
Table 34. North America End-Stage Kidney Disease Treatment Revenue by Country (2015-2020) (US$ Million)
Table 35. North America End-Stage Kidney Disease Treatment Revenue Market Share by Country (2015-2020)
Table 36. North America End-Stage Kidney Disease Treatment Sales by Type (2015-2020) (K Pcs)
Table 37. North America End-Stage Kidney Disease Treatment Sales Market Share by Type (2015-2020)
Table 38. North America End-Stage Kidney Disease Treatment Sales by Application (2015-2020) (K Pcs)
Table 39. North America End-Stage Kidney Disease Treatment Sales Market Share by Application (2015-2020)
Table 40. Europe End-Stage Kidney Disease Treatment Sales by Country (2015-2020) (K Pcs)
Table 41. Europe End-Stage Kidney Disease Treatment Sales Market Share by Country (2015-2020)
Table 42. Europe End-Stage Kidney Disease Treatment Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe End-Stage Kidney Disease Treatment Revenue Market Share by Country (2015-2020)
Table 44. Europe End-Stage Kidney Disease Treatment Sales by Type (2015-2020) (K Pcs)
Table 45. Europe End-Stage Kidney Disease Treatment Sales Market Share by Type (2015-2020)
Table 46. Europe End-Stage Kidney Disease Treatment Sales by Application (2015-2020) (K Pcs)
Table 47. Europe End-Stage Kidney Disease Treatment Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific End-Stage Kidney Disease Treatment Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific End-Stage Kidney Disease Treatment Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific End-Stage Kidney Disease Treatment Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific End-Stage Kidney Disease Treatment Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific End-Stage Kidney Disease Treatment Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific End-Stage Kidney Disease Treatment Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific End-Stage Kidney Disease Treatment Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific End-Stage Kidney Disease Treatment Sales Market Share by Application (2015-2020)
Table 56. Latin America End-Stage Kidney Disease Treatment Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America End-Stage Kidney Disease Treatment Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa End-Stage Kidney Disease Treatment Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America End-Stage Kidney Disease Treatment Revenue Market Share by Country (2015-2020)
Table 60. Latin America End-Stage Kidney Disease Treatment Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America End-Stage Kidney Disease Treatment Sales Market Share by Type (2015-2020)
Table 62. Latin America End-Stage Kidney Disease Treatment Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America End-Stage Kidney Disease Treatment Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa End-Stage Kidney Disease Treatment Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa End-Stage Kidney Disease Treatment Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa End-Stage Kidney Disease Treatment Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa End-Stage Kidney Disease Treatment Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa End-Stage Kidney Disease Treatment Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa End-Stage Kidney Disease Treatment Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa End-Stage Kidney Disease Treatment Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa End-Stage Kidney Disease Treatment Sales Market Share by Application (2015-2020)
Table 72. BLR Bio LLC Corporation Information
Table 73. BLR Bio LLC Description and Major Businesses
Table 74. BLR Bio LLC End-Stage Kidney Disease Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. BLR Bio LLC Product
Table 76. BLR Bio LLC Recent Development
Table 77. CTI BioPharma Corp Corporation Information
Table 78. CTI BioPharma Corp Description and Major Businesses
Table 79. CTI BioPharma Corp End-Stage Kidney Disease Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. CTI BioPharma Corp Product
Table 81. CTI BioPharma Corp Recent Development
Table 82. F. Hoffmann-La Roche Ltd Corporation Information
Table 83. F. Hoffmann-La Roche Ltd Description and Major Businesses
Table 84. F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. F. Hoffmann-La Roche Ltd Product
Table 86. F. Hoffmann-La Roche Ltd Recent Development
Table 87. Novartis AG Corporation Information
Table 88. Novartis AG Description and Major Businesses
Table 89. Novartis AG End-Stage Kidney Disease Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Novartis AG Product
Table 91. Novartis AG Recent Development
Table 92. Prolong Pharmaceuticals LLC Corporation Information
Table 93. Prolong Pharmaceuticals LLC Description and Major Businesses
Table 94. Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Prolong Pharmaceuticals LLC Product
Table 96. Prolong Pharmaceuticals LLC Recent Development
Table 97. VESSL Therapeutics Ltd Corporation Information
Table 98. VESSL Therapeutics Ltd Description and Major Businesses
Table 99. VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. VESSL Therapeutics Ltd Product
Table 101. VESSL Therapeutics Ltd Recent Development
Table 102. Global End-Stage Kidney Disease Treatment Sales Forecast by Regions (2021-2026) (K Pcs)
Table 103. Global End-Stage Kidney Disease Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 104. Global End-Stage Kidney Disease Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 105. Global End-Stage Kidney Disease Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 106. North America: End-Stage Kidney Disease Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 107. North America: End-Stage Kidney Disease Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Europe: End-Stage Kidney Disease Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. Europe: End-Stage Kidney Disease Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Asia Pacific: End-Stage Kidney Disease Treatment Sales Forecast by Region (2021-2026) (K Pcs)
Table 111. Asia Pacific: End-Stage Kidney Disease Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 112. Latin America: End-Stage Kidney Disease Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 113. Latin America: End-Stage Kidney Disease Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Middle East and Africa: End-Stage Kidney Disease Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 115. Middle East and Africa: End-Stage Kidney Disease Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 117. Key Challenges
Table 118. Market Risks
Table 119. Main Points Interviewed from Key End-Stage Kidney Disease Treatment Players
Table 120. End-Stage Kidney Disease Treatment Customers List
Table 121. End-Stage Kidney Disease Treatment Distributors List
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. End-Stage Kidney Disease Treatment Product Picture
Figure 2. Global End-Stage Kidney Disease Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. MK-3866 Product Picture
Figure 4. Pacritinib Product Picture
Figure 5. Sanguinate Product Picture
Figure 6. Tesidolumab Product Picture
Figure 7. Others Product Picture
Figure 8. Global End-Stage Kidney Disease Treatment Sales Market Share by Application in 2020 & 2026
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. End-Stage Kidney Disease Treatment Report Years Considered
Figure 13. Global End-Stage Kidney Disease Treatment Market Size 2015-2026 (US$ Million)
Figure 14. Global End-Stage Kidney Disease Treatment Sales 2015-2026 (K Pcs)
Figure 15. Global End-Stage Kidney Disease Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global End-Stage Kidney Disease Treatment Sales Market Share by Region (2015-2020)
Figure 17. Global End-Stage Kidney Disease Treatment Sales Market Share by Region in 2019
Figure 18. Global End-Stage Kidney Disease Treatment Revenue Market Share by Region (2015-2020)
Figure 19. Global End-Stage Kidney Disease Treatment Revenue Market Share by Region in 2019
Figure 20. Global End-Stage Kidney Disease Treatment Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by End-Stage Kidney Disease Treatment Revenue in 2019
Figure 22. End-Stage Kidney Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global End-Stage Kidney Disease Treatment Sales Market Share by Type (2015-2020)
Figure 24. Global End-Stage Kidney Disease Treatment Sales Market Share by Type in 2019
Figure 25. Global End-Stage Kidney Disease Treatment Revenue Market Share by Type (2015-2020)
Figure 26. Global End-Stage Kidney Disease Treatment Revenue Market Share by Type in 2019
Figure 27. Global End-Stage Kidney Disease Treatment Market Share by Price Range (2015-2020)
Figure 28. Global End-Stage Kidney Disease Treatment Sales Market Share by Application (2015-2020)
Figure 29. Global End-Stage Kidney Disease Treatment Sales Market Share by Application in 2019
Figure 30. Global End-Stage Kidney Disease Treatment Revenue Market Share by Application (2015-2020)
Figure 31. Global End-Stage Kidney Disease Treatment Revenue Market Share by Application in 2019
Figure 32. North America End-Stage Kidney Disease Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America End-Stage Kidney Disease Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America End-Stage Kidney Disease Treatment Sales Market Share by Country in 2019
Figure 35. North America End-Stage Kidney Disease Treatment Revenue Market Share by Country in 2019
Figure 36. U.S. End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America End-Stage Kidney Disease Treatment Market Share by Type in 2019
Figure 41. North America End-Stage Kidney Disease Treatment Market Share by Application in 2019
Figure 42. Europe End-Stage Kidney Disease Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe End-Stage Kidney Disease Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe End-Stage Kidney Disease Treatment Sales Market Share by Country in 2019
Figure 45. Europe End-Stage Kidney Disease Treatment Revenue Market Share by Country in 2019
Figure 46. Germany End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe End-Stage Kidney Disease Treatment Market Share by Type in 2019
Figure 57. Europe End-Stage Kidney Disease Treatment Market Share by Application in 2019
Figure 58. Asia Pacific End-Stage Kidney Disease Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific End-Stage Kidney Disease Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific End-Stage Kidney Disease Treatment Sales Market Share by Region in 2019
Figure 61. Asia Pacific End-Stage Kidney Disease Treatment Revenue Market Share by Region in 2019
Figure 62. China End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific End-Stage Kidney Disease Treatment Market Share by Type in 2019
Figure 85. Asia Pacific End-Stage Kidney Disease Treatment Market Share by Application in 2019
Figure 86. Latin America End-Stage Kidney Disease Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America End-Stage Kidney Disease Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America End-Stage Kidney Disease Treatment Sales Market Share by Country in 2019
Figure 89. Latin America End-Stage Kidney Disease Treatment Revenue Market Share by Country in 2019
Figure 90. Mexico End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America End-Stage Kidney Disease Treatment Market Share by Type in 2019
Figure 97. Latin America End-Stage Kidney Disease Treatment Market Share by Application in 2019
Figure 98. Middle East and Africa End-Stage Kidney Disease Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa End-Stage Kidney Disease Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa End-Stage Kidney Disease Treatment Sales Market Share by Country in 2019
Figure 101. Middle East and Africa End-Stage Kidney Disease Treatment Revenue Market Share by Country in 2019
Figure 102. Turkey End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa End-Stage Kidney Disease Treatment Market Share by Type in 2019
Figure 109. Middle East and Africa End-Stage Kidney Disease Treatment Market Share by Application in 2019
Figure 110. North America End-Stage Kidney Disease Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America End-Stage Kidney Disease Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe End-Stage Kidney Disease Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe End-Stage Kidney Disease Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific End-Stage Kidney Disease Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific End-Stage Kidney Disease Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America End-Stage Kidney Disease Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America End-Stage Kidney Disease Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa End-Stage Kidney Disease Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa End-Stage Kidney Disease Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
末期腎疾患（ESRD）治療薬の世界市場（～2026年） Market Analysis and Insights: Global End-Stage Renal Disease (ESRD) Drugs Market The global End-Stage Renal Disease (ESRD) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global End-Stage Renal Disease (ESRD) Drugs Scop…- 慢性腎臓病（CKD）の世界市場（～2026年） Market Analysis and Insights: Global Chronic Kidney Disease (CKD) Market The global Chronic Kidney Disease (CKD) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chronic Kidney Disease (CKD) Scope and Market Size Chroni…
- クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
- クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
- レイノー病治療の世界市場（～2026年） Market Analysis and Insights: Global Raynauds Disease Treatment Market The global Raynauds Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Raynauds Disease Treatment Scope and Market Size Raynauds Dis…